Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.7977
+0.0077 (0.97%)
Aug 15, 2025, 10:43 AM - Market open
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $61.30 million as of August 15, 2025. Its market cap has increased by 64.73% in one year.
Market Cap
61.30M
Enterprise Value
40.38M
1-Year Change
64.73%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $226.28M to $61.30M, a decrease of -72.91%. That is a compound annual growth rate of -15.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 60.71M | -12.08% |
| Dec 31, 2024 | 69.05M | -42.03% |
| Dec 29, 2023 | 119.13M | -2.89% |
| Dec 30, 2022 | 122.67M | -65.85% |
| Dec 31, 2021 | 359.22M | -5.17% |
| Dec 31, 2020 | 378.78M | 3.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |